145 related articles for article (PubMed ID: 38166565)
1. A preliminary exploration on the mechanism of the carbapenem-resistance transformation of Serratia marcescens in vivo.
Xu Q; Zheng B; Li K; Shen P; Xiao Y
BMC Genomics; 2024 Jan; 25(1):2. PubMed ID: 38166565
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the molecular characteristics of a blaKPC-2-harbouring untypeable plasmid in Serratia marcescens.
Wang X; Xiao W; Li L; Jing M; Sun M; Chang Y; Qu Y; Jiang Y; Xu Q
Int Microbiol; 2022 May; 25(2):237-244. PubMed ID: 34232406
[TBL] [Abstract][Full Text] [Related]
3. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
Cai JC; Zhou HW; Zhang R; Chen GX
Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
[TBL] [Abstract][Full Text] [Related]
4. Genomic characterization of two carbapenem-resistant
Jia J; Huang L; Zhang L; Sheng Y; Chu W; Xu H; Xu A
Front Cell Infect Microbiol; 2023; 13():1075255. PubMed ID: 36844412
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains.
Bolourchi N; Noori Goodarzi N; Giske CG; Nematzadeh S; Haririzadeh Jouriani F; Solgi H; Badmasti F
Gene; 2022 May; 822():146355. PubMed ID: 35189248
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme.
Gales AC; Biedenbach DJ; Winokur P; Hacek DM; Pfaller MA; Jones RN
Diagn Microbiol Infect Dis; 2001 Feb; 39(2):125-7. PubMed ID: 11248526
[TBL] [Abstract][Full Text] [Related]
8. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
[TBL] [Abstract][Full Text] [Related]
9. SMB-1, a novel subclass B3 metallo-beta-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate.
Wachino J; Yoshida H; Yamane K; Suzuki S; Matsui M; Yamagishi T; Tsutsui A; Konda T; Shibayama K; Arakawa Y
Antimicrob Agents Chemother; 2011 Nov; 55(11):5143-9. PubMed ID: 21876060
[TBL] [Abstract][Full Text] [Related]
10. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.
Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J
Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839
[TBL] [Abstract][Full Text] [Related]
11. Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.
Biagi M; Shajee A; Vialichka A; Jurkovic M; Tan X; Wenzler E
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932381
[TBL] [Abstract][Full Text] [Related]
12. In vivo acquisition of a plasmid-mediated bla(KPC-2) gene among clonal isolates of Serratia marcescens.
Tsakris A; Voulgari E; Poulou A; Kimouli M; Pournaras S; Ranellou K; Kosmopoulou O; Petropoulou D
J Clin Microbiol; 2010 Jul; 48(7):2546-9. PubMed ID: 20463153
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem antibiotic stress increases bla
Chen H; Li N; Wang F; Wang L; Liang W
J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and genotypic characteristics of a carbapenem-resistant Serratia marcescens cohort and outbreak: describing an opportunistic pathogen.
Prado G; Mendes ET; Martins RCR; Perdigão-Neto LV; Freire MP; Marchi AP; Côrtes MF; Lima VACC; Rossi F; Guimarães T; Levin AS; Costa SF
Int J Antimicrob Agents; 2022 Jan; 59(1):106463. PubMed ID: 34715332
[TBL] [Abstract][Full Text] [Related]
15. Carbapenem-resistant Serratia marcescens bloodstream infection in hematopoietic stem cell transplantation patients: Will it be the next challenge?
do Prado GVB; Mendes ET; Martins RCR; Perdigão-Neto LV; Freire MP; Spadão F; de Castro Lima VAC; Rossi F; Guimarães T; Levin AS; Rocha V; Costa SF
Transpl Infect Dis; 2021 Aug; 23(4):e13630. PubMed ID: 33915010
[TBL] [Abstract][Full Text] [Related]
16. Molecular Characterization of Carbapenem-Resistant
Xu Q; Fu Y; Zhao F; Jiang Y; Yu Y
Infect Drug Resist; 2020; 13():999-1008. PubMed ID: 32308441
[TBL] [Abstract][Full Text] [Related]
17. SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.
Queenan AM; Torres-Viera C; Gold HS; Carmeli Y; Eliopoulos GM; Moellering RC; Quinn JP; Hindler J; Medeiros AA; Bush K
Antimicrob Agents Chemother; 2000 Nov; 44(11):3035-9. PubMed ID: 11036019
[TBL] [Abstract][Full Text] [Related]
18. Outbreak of meropenem-resistant Serratia marcescens comediated by chromosomal AmpC beta-lactamase overproduction and outer membrane protein loss.
Suh B; Bae IK; Kim J; Jeong SH; Yong D; Lee K
Antimicrob Agents Chemother; 2010 Dec; 54(12):5057-61. PubMed ID: 20876374
[TBL] [Abstract][Full Text] [Related]
19. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants.
Marumo K; Nagaki T; Nakamura Y
J Antimicrob Chemother; 1996 Jul; 38(1):47-58. PubMed ID: 8858456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
